Fig. 7: Changes in the expression of GAS5 and miR-1912-3p.
From: Role of Sox9 in BPD and its effects on the Wnt/β-catenin pathway and AEC-II differentiation
A Expression level of GAS5 and miR-1912-3p in lung tissue (n = 6). B Expression level of GAS5 and miR-1912-3p in the in vitro cell model. C Relative levels of Sox9 mRNAs and protein after the GAS5 intervention.Target band intensity was normalized to β-actin (This blot is the cropped image). (***P < 0.005 and ****P < 0.001 compared with the control group). D Sox9(red)+ SPC (green) immunofluorescence double staining in primary cell model. E Sox9 (red) + AQP5 (green) immunofluorescence double staining in primary cell model. F Double luciferase report of GAS5 and miR-1912-3p. 7G: Double luciferase report of Sox9 and miR-1912-3p.
